HSIC Henry Schein, Inc. - Common Stock
NASDAQ · Health Care · عرض على SEC EDGAR ↗ إغلاق أكتوبر 2, 2026 10-K/10-Q أغسطس 4, 2026HSIC لقطة سريعة للسهم السعر، القيمة السوقية، مكرر الربحية (P/E)، ربحية السهم (EPS)، العائد على حقوق الملكية (ROE)، نسبة الدين إلى حقوق الملكية، نطاق 52 أسبوعًا
HSIC مخطط سعر السهم OHLCV يومي مع مؤشرات فنية — تحريك وتكبير وتخصيص عرضك
تتكيف دقة الشريط مع الفترة المحددة - مرر مؤشر الفأرة فوق الرسم البياني لرؤية الافتتاح/الأعلى/الأدنى/الإغلاق للشريط.
| تاريخ الاستحقاق | تقسيم | النوع |
|---|---|---|
| 8 فبراير، 2019 | 51-for-40 | أمامي |
| 15 سبتمبر، 2017 | 2-for-1 | أمامي |
| 1 مارس، 2005 | 2-for-1 | أمامي |
حول Henry Schein, Inc. - Common Stock نظرة عامة على الشركة من ويكيبيديا
Henry Schein, Inc. is an American distributor of health care products and services, with operations in 33 countries and territories. It is the world's largest provider of health care solutions to office-based dental and medical practitioners.
History
In 1932, Henry Schein, a graduate of Columbia University College of Pharmacy, borrowed $500 and opened a pharmacy in Queens, New York. The company expanded into dental supplies in the 1960s, and by the late 1980s, Henry Schein held approximately 10 percent of the dental-supply market. Marvin Schein, Henry Schein's son, took over management of daily operations in 1971.
In 1978, founder Henry Schein's son Jay Schein became CEO of the company. When Jay Schein died of cancer in 1989, Stanley Bergman took over as CEO. Bergman was born in South Africa and came to New York in 1976, where he became an accountant. In 1980, he joined Henry Schein and was promoted to CFO.
Henry Schein Inc. filed with the U.S. Securities and Exchange Commission in 1995 to sell 6.2 million shares in an initial public offering with William Blair & Company as the lead underwriter. The IPO raised $72.8 million and began trading on the Nasdaq. By 1996, the company was up to $1.4 billion in sales and $29 million in profit under Bergman's leadership. That year, the company made seventeen acquisitions.
In August 1997, Henry Schein Inc. agreed to buy Sullivan Dental Products Inc. for approximately $318 million. The purchase made the company the world's largest distributor of dental equipment and supplies. By that point, Henry Schein had made 16 acquisitions in 1997. Also in 1997, Henry Schein acquired New York-based medical-products distributor Micro BioMedics Inc as well as Dentrix Dental Systems.
Henry Schein announced the acquisition of demedis GmbH and Euro Dental Holding GmbH in June 2004. In November 2009, it was announced that Henry Schein Inc. and Butler Animal Health Supply would be launching joint venture Butler Schein Animal Health, the largest veterinary sales and distribution company in the United States. Butler Schein Animal Health was rebranded as Henry Schein Animal Health in 2013. Between 1989 and 2016, Henry Schein purchased approximately 200 companies. The company's chief executive officer, Stanley Bergman, was announced as Chief Executive Magazine's CEO of the Year in May 2017.
In 2018, the FTC accused Benco Dental, Patterson Companies, and Henry Schein of violating antitrust laws. In October 2019, the FTC's Chief Administrative Law Judge dismissed the claims against Henry Schein while finding that Benco and Patterson violated U.S. antitrust laws.
In February 2019, Henry Schein spun off the company's animal health business and merged it with Vets First Choice to form a new company. The new company is established as Covetrus.
Henry Schein Inc. was one of the six main defendants in lawsuits with state and local governments of the opioid epidemic in the United States. The company was dismissed as a defendant in October 2019 in the bellwether Summit County, Ohio litigation.
In July 2022, Henry Schein acquired Condor Dental, a dental distribution company.
In April 2023, Henry Schein acquired Biotech Dental, a provider of dental implants, clear aligners, and digital dental software, based in Salon-de-Provence, France.
In July 2023, Henry Schein acquired S.I.N Implant System, a major provider of dental implants in Brazil.
On October 14, 2023, Henry Schein reported a major hack into its core systems, which included investor information, and payroll data - amounting to 35 Terabytes of data being exfiltrated from the company. This resulted in its applications and e-commerce site being unavailable for several days.
In July 2025, Henry Schein announced that Stanley Bergman would be stepping down as CEO at the end of 2025, however he will continue to serve as chairman of the board. In January 2026 the company announced Bergman's successor as Frederick Lowery, Executive Vice President and President, Laboratory Products and BioProduction at Thermo Fisher Scientific.
In 2025, Henry Schein ranked 333rd by revenue on the Fortune 500 list and 34th within the healthcare sector.
Operations
Dental
In 1997, Henry Schein acquired Sullivan Dental Products and Dentrix Dental Systems, making it the world's largest distributor of dental equipment and supplies.
Dentrix Ascend, is a cloud-based dental practice management software platform developed by Henry Schein One for dental offices. The software is accessible through a web browser and includes tools of scheduling, billing, patient records, imaging, and practice management.
Henry Schein established the Henry Schein Dental Business Institute in March 2015 to teach owners and operators of dental practices the fundamentals of business. The first class to complete the program graduated in March 2016. Henry Schein also launched the Henry Schein Digital Dentistry Program at Temple University's Maurice H. Kornberg School of Dentistry in 2016.
In May 2016, Henry Schein's entity Dentrix presented the DEXIS software's ability to integrate X-rays into a patient's chart. Zahn Dental, Henry Schein's laboratory supply business, acquired Custom Automated Prosthetics in June 2016. The acquisition enabled Henry Schein to expand its prosthetic offerings.
In August 2019, Henry Schein acquired a majority equity stake in Cliniclands, a distributor serving dental practices throughout Sweden, Denmark, and Norway.
In May 2021, Henry Schein announced it acquired an 80% ownership position in Jarvis Analytics, a software company that develops comprehensive data analytics tools for dental practitioners.
In June 2021, Henry Schein acquired a 70% ownership position in eAssist Dental Solutions (eAssist), the developer of a virtual dental billing outsourcing service.
In August 2022, Henry Schein acquired Midway Dental Supply, a full-service dental distributor serving across the Midwestern United States.
In January 2023, Henry Schein announced its subsidiary, eAssist Dental Solutions (eAssist), acquired a majority interest in Unitas PPO Solutions (Unitas), a service provider that works with dental practices to assess their commercial insurance participation, set competitive fee-for-service rates, and negotiate contracted reimbursement with commercial insurers.
In July 2024, Henry Schein acquired abc dental AG, a full-service dental distributor offering consumables, equipment, and technical service to general practitioners, specialists, and dental laboratories in Switzerland.
Henry Schein One
In July 2018, Henry Schein and Internet Brands completed a joint venture to form Henry Schein One. The new company delivers integrated dental technology to help improve practice management and marketing as well as patient communication. Since the formation, Henry Schein One has included Dentrix, Dentrix Ascend, Dentalplans.com, Demandforce, Sesame Communications, and Officite as part of its portfolio of dental technology products.
In July 2019, Henry Schein One acquired Elite Computer Italia S.r.L. (Elite), a full-service software company that delivers practice management solutions to dental practices in Italy.
In November 2022, Henry Schein One announced a partnership with VideaHealth, a dental AI platform. As a result, Henry Schein One introduced Dentrix Detect AI, an AI-enabled X-Ray analysis tool. The integration with VideaHealth's FDA-cleared computer-assisted detection (CADe) device can help oral health professionals use AI in dental practices.
In December 2023, Henry Schein One was named to Utah Business Magazine's Best Companies to Work For list.
Medical
In November 2014, Henry Schein Medical announced a strategic arrangement with Cardinal Health. Cardinal Health's physician office-sales organization consolidated into Henry Schein Medical.
In March 2019, Henry Schein acquired North American Rescue (NAR), the leading provider of survivability and casualty-care medical products to the defense and public-safety markets.
In January 2021, Henry Schein acquired a majority ownership position in Prism Medical Products, LLC (PRISM), a nationwide provider of specialty home medical supplies with a core competency in advanced wound care products.
In October 2023, Henry Schein acquired Shield Healthcare, Inc., a supplier of homecare medical products delivered directly to patients in their homes.
In April 2024, Henry Schein acquired TriMed, a developer of orthopedic devices for lower extremities (foot and ankle) and upper extremities (hand and wrist).
In January 2025, Henry Schein acquired all of the assets of Acentus, a medical supplier specializing in Continuous Glucose Monitors (CGMs).
Former division
Animal health
Henry Schein has spun off this division in early 2019 produces software that is used in veterinary practices designed to improve communication and data management including the online cloud-based application, Rapport. In February 2016, Henry Schein released Axis-Q, a software application designed to ease the recording and access of veterinary medical records.
Philanthropy
In 1998, Henry Schein's Back to School program was launched; this program provides underserved children with school supplies and has helped over 65,000 students since its foundation.
Since 1999, Henry Schein has held its annual ‘Holiday Cheer for Children’ program, which donates clothing, toys, and gift cards to over 20,000 children and their families throughout the holiday season.
In 2015, the Alpha Omega International Dental Society and Henry Schein Cares partnered to create the Alpha Omega-Henry Schein Cares Holocaust Survivors Oral Health Program, which offers pro bono oral care to Holocaust survivors. Since its inception, the program has provided treatment to over 1,600 individuals in the United States and Canada.
Since 2018, Henry Schein has supported the Special Olympics, in particular its Healthy Athletes program, through essential health care donations.
In April 2023, Henry Schein launched its Practice Green initiative, which seeks to encourage healthcare professionals to transition towards sustainable practices.
Henry Schein has also served as the exclusive product sponsor for the American Dental Association’s Give Kids A Smile Program. Henry Schein has contributed $20 million in oral health care products and more than 40,000 dental kits.
In April 2025, the Science Based Targets initiative (SBTi) approved Henry Schein's near-term and long-term science-based emissions reduction targets, verifying its net-zero science-based target by 2050.
المصدر: ويكيبيديا (الإنجليزية), CC BY-SA 4.0 · عرض على ويكيبيديا ↗
أداء 10 سنوات اتجاهات الإيرادات وصافي الدخل والهوامش وربحية السهم
التقييم نسب مكرر الربحية (P/E)، مكرر المبيعات (P/S)، مكرر القيمة الدفترية (P/B)، EV/EBITDA — هل السهم مرتفع السعر أم رخيص؟
| المقياس | اتجاه 5 سنوات | HSIC | متوسط 5 سنوات | متوسط الأقران | الحكم |
|---|---|---|---|---|---|
| P/E (سنوي حالي) | 24.7متوسط 5 سنوات ≈21.5 | ≈21.5 | 22.9 | مبالغ في تقييمه | |
| السعر/المبيعات (سنوي حالي) | 0.7متوسط 5 سنوات ≈0.8 | ≈0.8 | 0.5 | مبالغ في تقييمه | |
| السعر / القيمة الدفترية (الربع الأخير) | 3.0متوسط 5 سنوات ≈2.8 | ≈2.8 | · | · | |
| EV / EBITDA | 10.7متوسط 5 سنوات ≈10.4 | ≈10.4 | · | · | |
| السعر / التدفق النقدي الحر (سنوي حالي) | 16.7متوسط 5 سنوات ≈18.5 | ≈18.5 | · | · | |
| السعر / التدفق النقدي (سنوي حالي) | 13.6متوسط 5 سنوات ≈14.8 | ≈14.8 | 14.0 | القيمة العادلة | |
| EV / Revenue (القيمة المؤسسية / الإيرادات) | 0.8متوسط 5 سنوات ≈0.8 | ≈0.8 | · | · | |
| EV / FCF (القيمة المؤسسية / التدفق النقدي الحر) | 18.0متوسط 5 سنوات ≈18.9 | ≈18.9 | · | · | |
| السعر / القيمة الدفترية الملموسة (الربع الأخير) | 4.3 | · | · | · | |
| PEG Ratio (نسبة السعر إلى الأرباح إلى النمو (PEG)) | ≈8.2 | · | · | · |
يتم حساب الوسيط النظير على أساس موحد لكل مقياس وقد لا يتطابق دائمًا مع الأساس السنوي الحالي/الربع الأخير المعروض لهذا السهم.
الربحية هامش الربح الإجمالي والتشغيلي والصافي؛ العائد على حقوق الملكية (ROE)، العائد على الأصول (ROA)، العائد على رأس المال المستثمر (ROIC)
| المقياس | اتجاه 5 سنوات | HSIC | متوسط 5 سنوات | متوسط الأقران | الحكم |
|---|---|---|---|---|---|
| هامش الربح الإجمالي (سنوي حالي) | 31.3%متوسط 5 سنوات ≈30.8% | ≈30.8% | 4.3% | من الدرجة الأولى | |
| هامش التشغيل (سنوي حالي) | 5.0%متوسط 5 سنوات ≈5.5% | ≈5.5% | 1.1% | من الدرجة الأولى | |
| هامش EBITDA (سنوي حالي) | 7.4%متوسط 5 سنوات ≈7.5% | ≈7.5% | 1.3% | من الدرجة الأولى | |
| هامش ما قبل الضريبة (سنوي حالي) | 4.1%متوسط 5 سنوات ≈5.0% | ≈5.0% | 1.0% | من الدرجة الأولى | |
| هامش صافي الربح (سنوي حالي) | 3.0%متوسط 5 سنوات ≈3.8% | ≈3.8% | 0.63% | من الدرجة الأولى | |
| العائد على الأصول (سنوي حالي) | 3.6%متوسط 5 سنوات ≈5.2% | ≈5.2% | 3.1% | من الدرجة الأولى | |
| ROE (سنوي حالي) | 12.2%متوسط 5 سنوات ≈13.8% | ≈13.8% | -4.6% | من الدرجة الأولى | |
| ROIC | 12.4%متوسط 5 سنوات ≈14.2% | ≈14.2% | 12.2% | من الدرجة الأولى |
الصحة المالية الديون، السيولة، الملاءة المالية — قوة الميزانية العمومية
| المقياس | اتجاه 5 سنوات | HSIC | متوسط 5 سنوات | متوسط الأقران | الحكم |
|---|---|---|---|---|---|
| الدين / حقوق الملكية (الربع الأخير) | 0.3متوسط 5 سنوات ≈0.1 | ≈0.1 | 0.3 | متوافق | |
| النسبة الحالية (الربع الأخير) | 1.3متوسط 5 سنوات ≈1.6 | ≈1.6 | 0.9 | سيولة قوية | |
| Quick Ratio (النسبة السريعة) | 0.6متوسط 5 سنوات ≈0.7 | ≈0.7 | 0.5 | سيولة قوية | |
| Interest Coverage (تغطية الفائدة) | 4.4متوسط 5 سنوات ≈12.8 | ≈12.8 | 5.9 | سيولة منخفضة |
النمو نمو الإيرادات وربحية السهم وصافي الدخل: مقارنة بالعام السابق (YoY)، متوسط النمو السنوي المركب لـ 3 سنوات (3Y CAGR)، متوسط النمو السنوي المركب لـ 5 سنوات (5Y CAGR)
| المقياس | اتجاه 5 سنوات | HSIC | متوسط 5 سنوات | متوسط الأقران | الحكم |
|---|---|---|---|---|---|
| Revenue YoY (الإيرادات مقارنة بالعام السابق) | 4.0%متوسط 5 سنوات ≈5.8% | ≈5.8% | · | · | |
| Revenue CAGR 3Y (معدل نمو الإيرادات السنوي المركب لـ 3 سنوات) | 1.4%متوسط 5 سنوات ≈3.0% | ≈3.0% | · | · | |
| Revenue CAGR 5Y (معدل نمو الإيرادات السنوي المركب لـ 5 سنوات) | 5.4% | · | · | · | |
| EPS YoY (ربحية السهم على أساس سنوي) | 7.2%متوسط 5 سنوات ≈6.0% | ≈6.0% | · | · | |
| Net Income YoY (صافي الدخل مقارنة بالعام السابق) | 2.1%متوسط 5 سنوات ≈2.9% | ≈2.9% | · | · | |
| EPS CAGR 3Y (متوسط نمو ربحية السهم السنوي لـ 3 سنوات) | -5.8%متوسط 5 سنوات ≈-4.6% | ≈-4.6% | · | · | |
| EPS CAGR 5Y (متوسط نمو ربحية السهم السنوي لـ 5 سنوات) | 3.0% | · | · | · | |
| Net Income CAGR 3Y (متوسط نمو صافي الدخل السنوي لـ 3 سنوات) | -9.6%متوسط 5 سنوات ≈-7.8% | ≈-7.8% | · | · | |
| Net Income CAGR 5Y (متوسط نمو صافي الدخل السنوي لـ 5 سنوات) | -0.30% | · | · | · |
كفاءة رأس المال معدل دوران الأصول، معدل دوران المخزون، معدل دوران المستحقات
| المقياس | اتجاه 5 سنوات | HSIC | متوسط 5 سنوات | متوسط الأقران | الحكم |
|---|---|---|---|---|---|
| Asset Turnover (دوران الأصول) | 1.2متوسط 5 سنوات ≈1.3 | ≈1.3 | 4.5 | ضعيف | |
| Inventory Turnover (دوران المخزون) | 4.8متوسط 5 سنوات ≈4.8 | ≈4.8 | 15.7 | ضعيف | |
| Receivables Turnover (دوران المستحقات) | 8.4متوسط 5 سنوات ≈8.2 | ≈8.2 | 13.1 | ضعيف | |
| Revenue / Employee (الإيرادات / الموظف) | ≈$527.4K | · | · | · |
القيمة · ≈ متوسط 5 سنوات · متوسط الصناعة · حكم مقارنة بالمتوسط
سجل الأرباح ربحية السهم الفعلية مقابل التقديرات، نسبة المفاجأة %، معدل التجاوز، تاريخ الأرباح التالي
| الفترة | تقرير | EPS Actual | EPS المتوقع | المفاجأة |
|---|---|---|---|---|
| 30 يونيو، 2026 | أغسطس 11, 2026 | $1.27 | $1.26 | 0.67% |
| 31 مارس، 2026 | مايو 12, 2026 | $1.32 | $1.24 | 6.3% |
| 31 ديسمبر، 2025 | $1.34 | $1.33 | 1.1% | |
| 30 سبتمبر، 2025 | $1.38 | $1.30 | 5.8% | |
| 30 يونيو، 2025 | $1.10 | $1.22 | -9.5% | |
| 31 مارس، 2025 | $1.15 | $1.13 | 1.6% |
الأساسيات الكاملة جميع المقاييس حسب السنة — قائمة الدخل، الميزانية العمومية، التدفق النقدي
قائمة الدخل
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $13.18B | $12.67B | $12.34B | $12.65B | $12.40B | $10.12B | $9.99B | $9.42B | $8.88B | $11.57B | $10.63B | |
| Cost of Revenue | $9.08B | $8.66B | $8.48B | $8.82B | $8.73B | $7.30B | $6.89B | $6.51B | $6.14B | $8.35B | $7.62B | |
| Gross Profit | $4.11B | $4.02B | $3.86B | $3.83B | $3.67B | $2.82B | $3.09B | $2.91B | $2.75B | $3.23B | $3.01B | |
| SG&A Expense | $3.08B | $3.03B | $2.96B | $2.77B | $2.63B | $2.09B | $2.36B | $2.22B | $2.07B | $2.41B | $2.24B | |
| Operating Expenses | · | · | · | · | · | · | · | $2.70B | $2.53B | $2.41B | · | |
| Operating Income | $653M | $621M | $615M | $747M | $852M | $535M | $718M | $601M | $670M | $772M | $734M | |
| Interest Expense | $150M | $131M | $87M | $35M | $27M | $41M | $51M | $76M | $51M | $32M | $26M | |
| Interest Income | $33M | $24M | $17M | $8M | $6M | $10M | $16M | $15M | $12M | $13M | $13M | |
| Other Non-op | $-3M | $-1M | $-3M | $1M | $0 | $-4M | $-3M | $-3M | $-1M | $3M | $-141.0K | |
| Pretax Income | $533M | $513M | $542M | $721M | $831M | $500M | $680M | $537M | $630M | $756M | $721M | |
| Income Tax | $126M | $128M | $120M | $170M | $198M | $95M | $160M | $107M | $309M | $218M | $211M | |
| Net Income | $398M | $390M | $416M | $538M | $631M | $404M | $695M | $536M | $406M | $507M | $479M | |
| EPS (Basic) | $3.29 | $3.07 | $3.18 | $3.95 | $4.51 | $2.83 | $4.70 | $3.51 | $2.59 | $3.14 | $2.89 | |
| EPS (Diluted) | $3.27 | $3.05 | $3.16 | $3.91 | $4.45 | $2.82 | $4.65 | $3.49 | $2.57 | $3.10 | $2.85 | |
| Shares (Basic) | 120,813,977 | 126,788,997 | 130,618,990 | 136,064,221 | 140,090,889 | 142,504,193 | 147,817,000 | 152,656,000 | 156,787,000 | 161,641,000 | 165,687,000 | |
| Shares (Diluted) | 121,717,876 | 127,779,228 | 131,748,171 | 137,755,670 | 141,772,781 | 143,403,682 | 149,257,000 | 153,707,000 | 158,208,000 | 163,723,000 | 168,250,000 | |
| EBITDA | $964M | $918M | $863M | $959M | $1.06B | $721M | $903M | $961M | · | $941M | $893M |
الميزانية العمومية
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $156M | $122M | $171M | $117M | $118M | $421M | · | $57M | $158M | $62M | $72M | |
| Receivables | $1.65B | $1.48B | $1.86B | $1.44B | $1.45B | $1.42B | $1.25B | $1.17B | $1.52B | $1.25B | $1.23B | |
| Inventory | $2.00B | $1.81B | $1.81B | $1.96B | $1.86B | $1.51B | $1.43B | $1.42B | $1.93B | $1.67B | $1.51B | |
| Prepaid Expense | $655M | $569M | $639M | $466M | $413M | $433M | $445M | $451M | $455M | $361M | $361M | |
| Current Assets | $4.46B | $3.98B | $4.49B | $3.99B | $3.84B | $3.79B | $3.23B | $4.18B | $4.09B | $3.34B | $3.23B | |
| PP&E (Net) | · | · | · | · | $366M | $342M | $330M | $314M | $375M | $334M | $318M | |
| PP&E (Gross) | $1.38B | $1.20B | $1.17B | $956M | $916M | $868M | $799M | $905M | $990M | $865M | $797M | |
| Accum. Depreciation | $759M | $670M | $672M | $573M | $550M | $526M | $469M | $591M | $615M | $531M | $478M | |
| Goodwill | $4.21B | $3.89B | $3.88B | $2.89B | $2.85B | $2.50B | $2.46B | $2.08B | $1.55B | $2.02B | $1.91B | |
| Intangibles | $1.02B | $1.02B | $916M | $587M | $668M | $479M | $573M | $376M | $670M | $621M | $593M | |
| Total Assets | $11.21B | $10.22B | $10.57B | $8.61B | $8.48B | $7.77B | $7.15B | $8.50B | $7.86B | $6.81B | $6.53B | |
| Accounts Payable | $1.15B | $962M | $1.02B | $1.00B | $1.05B | $1.01B | $880M | $786M | $1.15B | $1.01B | $1.01B | |
| Short-term Debt | $764M | $650M | $264M | $103M | $51M | $73M | $24M | $951M | · | · | · | |
| Current Liabilities | $3.23B | $2.80B | $2.68B | $2.22B | $2.31B | $2.28B | $2.04B | $3.22B | $2.83B | $2.32B | $2.15B | |
| Capital Leases | $251M | $259M | $310M | $275M | $268M | $239M | $176M | $0 | · | · | · | |
| Deferred Tax | $146M | $102M | $54M | $36M | $42M | $30M | $65M | $27M | $50M | $52M | $253M | |
| Other Non-current Liabilities | $486M | $387M | $436M | $361M | $377M | $393M | $331M | $358M | $420M | $264M | $212M | |
| Total Liabilities | $6.42B | $5.38B | $5.42B | $3.94B | $3.81B | $3.46B | $3.23B | $4.65B | $4.21B | $3.35B | $3.08B | |
| Long-term Debt | · | · | · | $1.05B | $822M | · | · | · | · | · | · | |
| Total Debt | $764M | $650M | $264M | $103M | $51M | $73M | $24M | · | · | · | · | |
| Paid-in Capital | $177M | $0 | $0 | $0 | $0 | $0 | $48M | $0 | · | · | · | |
| Retained Earnings | $3.29B | $3.77B | $3.86B | $3.68B | $3.60B | $3.45B | $3.12B | $3.21B | $2.94B | $2.98B | $2.90B | |
| AOCI | $-226M | $-379M | $-206M | $-233M | $-171M | $-108M | $-167M | $-249M | $-130M | $-317M | $-220M | |
| Stockholders' Equity | $3.25B | $3.39B | $3.65B | $3.45B | $3.42B | $3.35B | $3.00B | $2.96B | $2.81B | $2.79B | $2.88B | |
| Liabilities + Equity | $11.21B | $10.22B | $10.57B | $8.61B | $8.48B | $7.77B | $7.15B | $8.50B | $7.86B | $6.76B | $6.50B | |
| Shares Outstanding | 115,771,149 | 124,155,884 | 129,247,765 | 131,792,817 | 137,145,558 | 142,462,571 | 143,353,459 | 151,401,668 | 153,690,146 | 158,805,010 | 164,830,640 |
التدفق النقدي
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $311M | $297M | $248M | $212M | $210M | $186M | $185M | $144M | $134M | $170M | $159M | |
| Stock-based Comp | $39M | $39M | $39M | $54M | $78M | $9M | $45M | $33M | $37M | $58M | $45M | |
| Deferred Tax | $5M | $-61M | $-20M | $-73M | $-11M | $-53M | $-4M | $-25M | $1M | $-37M | $-6M | |
| Amort. of Intangibles | $180M | $185M | $152M | $126M | $124M | $106M | $108M | $75M | $70M | $98M | $93M | |
| Restructuring | $105M | $110M | $80M | $128M | $8M | · | · | $54M | $0 | $46M | $35M | |
| Other Non-cash | $-41M | $183M | $-183M | $-129M | $-199M | $54M | $-266M | $-54M | · | $-82M | $-90M | |
| Operating Cash Flow | $712M | $848M | $500M | $602M | $710M | $599M | $654M | $685M | $546M | $643M | $616M | |
| CapEx | $139M | $148M | $147M | $96M | $79M | $49M | $76M | $71M | $62M | $70M | $72M | |
| Investing Cash Flow | $-400M | $-430M | $-1.14B | $-276M | $-677M | $-115M | $-424M | $-193M | $-342M | $-316M | $-260M | |
| Debt Issued | $489M | $120M | $1.37B | $270M | $305M | $501M | $741.0K | $115M | $200M | $261M | $135M | |
| Net Debt Issued | $445M | $-198M | $900M | $211M | $183M | $-110M | $-260M | $87M | · | $245M | $-66M | |
| Stock Issued | $250M | $0 | $0 | · | · | · | · | · | · | · | · | |
| Stock Repurchased | $850M | $385M | $250M | $485M | $401M | $74M | $525M | $200M | $450M | $550M | $300M | |
| Net Stock Activity | $-600M | $-385M | $-250M | $-485M | $-401M | $-74M | $-525M | $-200M | · | $-550M | $-300M | |
| Financing Cash Flow | $-188M | $-510M | $701M | $-315M | $-333M | $-187M | $-216M | $-604M | $-113M | $-327M | $-348M | |
| Net Change in Cash | $34M | $-49M | $54M | $-1M | $-303M | $315M | $26M | $-94M | $225M | $-10M | $-17M | |
| Taxes Paid | $128M | · | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $573M | $700M | $353M | $506M | $631M | $550M | $578M | $594M | · | $545M | $515M | |
| Levered FCF | $458M | $602M | $285M | $472M | $610M | $517M | $539M | $533M | · | $523M | $497M |
الربحية
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 31.1% | 31.7% | 31.3% | 30.3% | 29.6% | 27.8% | 30.9% | 27.2% | · | 28.0% | 28.3% | |
| Operating Margin | 5.0% | 4.9% | 5.0% | 5.9% | 6.9% | 5.3% | 7.2% | 5.7% | · | 6.7% | 6.9% | |
| Net Margin | 3.0% | 3.1% | 3.4% | 4.2% | 5.1% | 4.0% | 7.0% | 4.1% | · | 4.4% | 4.5% | |
| Pretax Margin | 4.0% | 4.0% | 4.4% | 5.7% | 6.7% | 4.9% | 6.8% | 5.3% | · | 6.5% | 6.8% | |
| EBITDA Margin | 7.3% | 7.2% | 7.0% | 7.6% | 8.6% | 7.1% | 9.0% | 7.3% | · | 8.1% | 8.4% | |
| ROA | 3.7% | 3.8% | 4.3% | 6.3% | 7.8% | 5.4% | 8.9% | 6.6% | · | 7.6% | 7.6% | |
| ROE | 12.0% | 11.1% | 11.7% | 15.7% | 18.6% | 12.7% | 23.3% | 18.6% | · | 17.8% | 16.8% | |
| ROIC | 12.4% | 11.5% | 12.2% | 16.1% | 18.7% | 12.7% | 18.2% | 19.7% | · | 19.7% | 18.0% |
السيولة والملاءة
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.4 | 1.4 | 1.7 | 1.8 | 1.7 | 1.7 | 1.6 | 1.3 | · | 1.4 | 1.5 | |
| Quick Ratio | 0.6 | 0.6 | 0.8 | 0.7 | 0.7 | 0.6 | 0.6 | 0.5 | · | 0.6 | 0.6 | |
| Debt / Equity | 0.2 | 0.2 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | · | · | · | · | |
| Interest Coverage | 4.4 | 4.7 | 7.1 | 17.0 | 30.9 | 12.9 | 14.1 | 9.6 | · | 24.2 | 28.2 |
الكفاءة
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 1.2 | 1.2 | 1.3 | 1.5 | 1.5 | 1.4 | 1.3 | 1.6 | · | 1.7 | 1.7 | |
| Inventory Turnover | 4.8 | 4.8 | 4.5 | 4.6 | 5.2 | 5.0 | 4.8 | 4.9 | · | 5.3 | 5.4 | |
| Receivables Turnover | 8.4 | 7.6 | 7.5 | 8.7 | 8.6 | 7.6 | 8.3 | 8.4 | · | 9.3 | 9.0 |
لكل سهم
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $28.03 | $27.33 | $28.28 | $26.15 | $24.97 | $23.50 | $20.91 | $19.56 | · | $35.18 | $35.00 | |
| Revenue / Share | $108.32 | $99.18 | $93.66 | $91.81 | $87.47 | $70.56 | $66.90 | $85.89 | · | $141.36 | $126.36 | |
| Cash Flow / Share | $5.85 | $6.64 | $3.80 | $4.37 | $5.00 | $4.18 | $4.38 | $4.45 | · | $7.52 | $6.98 | |
| Cash / Share | $1.35 | $0.98 | $1.32 | $0.89 | $0.86 | · | · | $0.53 | · | $0.79 | $0.87 | |
| EPS (TTM) | $3.27 | $3.05 | $3.16 | $3.91 | $4.45 | $2.82 | $4.65 | $3.49 | · | $3.10 | $2.85 |
معدلات النمو
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 4.0% | 2.7% | -2.4% | 2.0% | 22.6% | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 1.4% | 0.73% | 6.8% | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 5.4% | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | 7.2% | -3.5% | -19.2% | -12.1% | 57.8% | · | · | · | · | · | · | |
| EPS CAGR 3Y | -5.8% | -11.8% | 3.9% | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 3.0% | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | 2.1% | -6.2% | -22.7% | -14.7% | 56.2% | · | · | · | · | · | · | |
| Net Income CAGR 3Y | -9.6% | -14.8% | 0.98% | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | -0.30% | · | · | · | · | · | · | · | · | · | · |
التقييم (آخر 12 شهرًا)
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $13.18B | $12.67B | $12.34B | $12.65B | $12.40B | $10.12B | $9.99B | $9.42B | · | $11.57B | $10.63B | |
| Net Income TTM | $398M | $390M | $416M | $538M | $631M | $404M | $695M | $536M | · | $507M | $479M | |
| Market Cap | $8.81B | $8.74B | $9.79B | $10.53B | $10.28B | $9.38B | $9.54B | $9.25B | · | $4.72B | $5.08B | |
| Enterprise Value | $9.42B | $9.27B | $9.88B | $10.51B | $10.21B | · | · | · | · | · | · | |
| P/E | 23.3 | 23.1 | 24.0 | 20.4 | 16.8 | 23.3 | 14.3 | 17.5 | · | 19.2 | 21.6 | |
| P/S | 0.7 | 0.7 | 0.8 | 0.8 | 0.8 | 0.9 | 1.0 | 1.0 | · | 0.4 | 0.5 | |
| P/B | 2.7 | 2.6 | 2.7 | 3.1 | 3.0 | 2.8 | 3.2 | 3.1 | · | 1.7 | 1.8 | |
| P / Tangible Book | · | · | · | · | · | 25.7 | · | · | · | · | · | |
| P / Cash Flow | 12.4 | 10.3 | 19.6 | 17.5 | 14.5 | 15.7 | 14.6 | 13.5 | · | 7.7 | 8.7 | |
| P / FCF | 15.4 | 12.5 | 27.7 | 20.8 | 16.3 | 17.0 | 16.5 | 15.6 | · | 8.7 | 9.9 | |
| EV / EBITDA | 9.8 | 10.1 | 11.4 | 11.0 | 9.6 | · | · | · | · | · | · | |
| EV / FCF | 16.4 | 13.2 | 28.0 | 20.8 | 16.2 | · | · | · | · | · | · | |
| EV / Revenue | 0.7 | 0.7 | 0.8 | 0.8 | 0.8 | · | · | · | · | · | · | |
| Earnings Yield | 4.3% | 4.3% | 4.2% | 4.9% | 5.9% | 4.3% | 7.0% | 5.7% | · | 5.2% | 4.6% |
قائمة الدخل
| المقياس | اتجاه | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.46B | $3.37B | $3.44B | $3.34B | $3.24B | $3.17B | $3.19B | $3.17B | $3.14B | $3.17B | $3.02B | $3.16B | $3.06B | $3.37B | $3.07B | |
| Cost of Revenue | $2.36B | $2.30B | $2.37B | $2.31B | $2.22B | $2.17B | $2.20B | $2.18B | $2.12B | $2.16B | $2.09B | $2.17B | $2.09B | $2.37B | $2.15B | |
| Gross Profit | $1.10B | $1.07B | $1.06B | $1.03B | $1.02B | $1.00B | $993M | $993M | $1.02B | $1.01B | $924M | $995M | $966M | $999M | $914M | |
| SG&A Expense | $831M | $809M | $808M | $760M | $778M | $738M | $738M | $724M | $781M | $791M | $807M | $725M | $717M | $761M | $648M | |
| Operating Income | $171M | $182M | $163M | $164M | $151M | $175M | $155M | $157M | $159M | $150M | $39M | $200M | $175M | $72M | $211M | |
| Interest Expense | $43M | $39M | $39M | $38M | $38M | $35M | $35M | $34M | $32M | $30M | $29M | $25M | $14M | $12M | $8M | |
| Interest Income | $8M | $7M | $9M | $9M | $9M | $6M | $6M | $7M | $6M | $5M | $5M | $6M | $3M | $3M | $1M | |
| Other Non-op | $1M | $0 | $0 | $-1M | $-1M | $-1M | $0 | $-2M | $-1M | $2M | $-1M | $-2M | $-1M | $0 | $1M | |
| Pretax Income | $137M | $150M | $133M | $134M | $121M | $145M | $126M | $128M | $132M | $127M | $14M | $179M | $163M | $63M | $205M | |
| Income Tax | $34M | $38M | $32M | $28M | $31M | $35M | $31M | $32M | $33M | $32M | $1M | $39M | $39M | $15M | $46M | |
| Net Income | $94M | $107M | $101M | $101M | $86M | $110M | $94M | $99M | $104M | $93M | $18M | $137M | $121M | $47M | $150M | |
| EPS (Basic) | $0.83 | $0.93 | $0.85 | $0.84 | $0.71 | $0.89 | $0.75 | $0.79 | $0.81 | $0.72 | $0.14 | $1.06 | $0.92 | $0.37 | $1.10 | |
| EPS (Diluted) | $0.82 | $0.92 | $0.85 | $0.84 | $0.70 | $0.88 | $0.75 | $0.78 | $0.80 | $0.72 | $0.14 | $1.05 | $0.91 | $0.36 | $1.09 | |
| Shares (Basic) | 113,451,329 | 114,939,640 | · | 120,199,552 | 121,927,867 | 123,776,073 | · | 126,124,715 | 127,784,380 | 128,720,661 | · | 130,388,353 | 131,365,789 | · | 135,608,678 | |
| Shares (Diluted) | 114,390,366 | 116,061,244 | · | 121,036,247 | 122,636,948 | 124,848,221 | · | 127,054,934 | 128,646,506 | 129,769,580 | · | 131,442,135 | 133,039,886 | · | 137,084,049 | |
| EBITDA | $255M | $263M | · | $244M | $151M | $248M | · | $157M | $159M | $223M | · | $200M | $227M | · | $211M |
الميزانية العمومية
| المقياس | اتجاه | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $157M | $138M | $156M | $136M | $145M | $127M | $122M | $126M | $138M | $159M | · | $166M | $126M | · | · | |
| Receivables | $1.76B | $1.72B | $1.65B | $1.74B | $1.65B | $1.58B | $1.48B | $1.66B | $1.56B | $1.64B | $1.86B | $1.57B | $1.47B | $1.44B | $1.51B | |
| Inventory | $2.06B | $2.01B | $2.00B | $1.91B | $1.91B | $1.84B | $1.81B | $1.75B | $1.66B | $1.69B | · | $1.83B | $1.92B | · | $1.82B | |
| Prepaid Expense | $621M | $625M | $655M | $604M | $545M | $490M | $569M | $607M | $587M | $589M | · | $541M | $438M | · | $509M | |
| Current Assets | $4.60B | $4.50B | $4.46B | $4.39B | $4.24B | $4.04B | $3.98B | $4.15B | $3.94B | $4.08B | · | $4.11B | $3.95B | · | $3.96B | |
| PP&E (Gross) | · | · | $1.38B | · | · | · | $1.20B | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $759M | · | · | · | $670M | · | · | · | · | · | · | · | · | |
| Goodwill | $4.27B | $4.28B | $4.21B | $4.15B | $4.08B | $3.96B | $3.89B | $3.99B | $3.90B | $3.83B | $3.88B | $3.60B | $2.92B | $2.89B | $2.87B | |
| Intangibles | $965M | $1.01B | $1.02B | $1.05B | $1.04B | $1.03B | $1.02B | $1.10B | $1.08B | $915M | · | $834M | $548M | · | $635M | |
| Total Assets | $11.38B | $11.30B | $11.21B | $11.10B | $10.91B | $10.48B | $10.22B | $10.61B | $10.25B | $10.14B | · | $9.81B | $8.57B | · | $8.53B | |
| Accounts Payable | $1.14B | $1.04B | $1.15B | $1.03B | $918M | $908M | $962M | $1.03B | $867M | $879M | · | $953M | $855M | · | $957M | |
| Short-term Debt | $1.02B | $1.05B | $764M | $913M | $901M | $867M | $650M | $638M | $505M | $264M | · | $12M | $236M | · | $107M | |
| Current Liabilities | $3.49B | $3.30B | $3.23B | $3.15B | $3.01B | $2.92B | $2.80B | $2.93B | $2.55B | $2.33B | · | $2.09B | $2.17B | · | $2.15B | |
| Capital Leases | $275M | $263M | $251M | $264M | $259M | $256M | $259M | $262M | $261M | $266M | · | $314M | $274M | · | $271M | |
| Deferred Tax | $153M | $158M | $146M | $144M | $147M | $135M | $102M | $123M | $115M | $77M | · | $91M | $40M | · | $37M | |
| Other Non-current Liabilities | $442M | $437M | $486M | $487M | $504M | $485M | $387M | $414M | $431M | $423M | · | $396M | $368M | · | $338M | |
| Total Liabilities | $6.66B | $6.48B | $6.42B | $6.20B | $6.01B | $5.76B | $5.38B | $5.63B | $5.25B | $5.11B | · | $4.71B | $3.88B | · | $3.73B | |
| Total Debt | $1.02B | $1.05B | · | $913M | $901M | $867M | · | $638M | $505M | $264M | · | $12M | · | · | $107M | |
| Paid-in Capital | $140M | $167M | $177M | $207M | $186M | $0 | $0 | $0 | $0 | $0 | · | $0 | $0 | · | $0 | |
| Retained Earnings | $3.20B | $3.29B | $3.29B | $3.38B | $3.48B | $3.63B | $3.77B | $3.77B | $3.80B | $3.84B | · | $3.90B | $3.68B | · | $3.92B | |
| AOCI | $-184M | $-189M | $-226M | $-222M | $-227M | $-317M | $-379M | $-264M | $-292M | $-239M | $-206M | $-247M | $-213M | $-233M | $-312M | |
| Stockholders' Equity | $3.16B | $3.27B | $3.25B | $3.36B | $3.44B | $3.31B | $3.39B | $3.50B | $3.51B | $3.60B | · | $3.65B | $3.47B | · | $3.61B | |
| Liabilities + Equity | $11.38B | $11.30B | $11.21B | $11.10B | $10.91B | $10.48B | $10.22B | $10.61B | $10.25B | $10.14B | · | $9.81B | $8.57B | · | $8.53B | |
| Shares Outstanding | 111,916,222 | 114,424,682 | 115,771,149 | 118,567,917 | 121,895,045 | 122,243,683 | 124,155,884 | 125,154,194 | 127,080,545 | 128,480,909 | 129,247,765 | 129,935,883 | 131,196,783 | 131,792,817 | 135,258,887 |
التدفق النقدي
| المقياس | اتجاه | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $84M | $81M | $82M | $80M | $76M | $73M | $76M | $74M | $74M | $73M | $68M | $69M | $52M | $52M | $52M | |
| Stock-based Comp | $13M | $3M | $10M | $13M | $11M | $5M | $9M | $10M | $12M | $8M | $1M | $14M | $10M | $10M | $17M | |
| Deferred Tax | $-10M | $2M | $5M | $7M | $0 | $-7M | $-20M | $-22M | $-21M | $2M | $-16M | $-1M | $2M | $-53M | $-5M | |
| Restructuring | $29M | $12M | $23M | $34M | $23M | $25M | $37M | $48M | $15M | $10M | · | $11M | $30M | · | $9M | |
| Other Non-cash | · | $-290M | · | · | · | $-144M | · | · | · | $21M | · | · | $-158M | · | · | |
| Operating Cash Flow | $242M | $-97M | $381M | $174M | $120M | $37M | $204M | $151M | $296M | $197M | $-32M | $231M | $27M | $254M | $98M | |
| CapEx | $30M | $25M | $43M | $33M | $32M | $31M | $36M | $34M | $37M | $41M | $39M | $40M | $31M | $29M | $24M | |
| Investing Cash Flow | $-65M | $-63M | $-147M | $-56M | $-98M | $-99M | $-58M | $-91M | $-209M | $-72M | $-327M | $-468M | $-39M | $-65M | $-152M | |
| Debt Issued | $87M | $57M | $175M | $70M | $94M | $150M | $0 | $30M | $0 | $90M | $210M | $750M | $31M | $105M | $165M | |
| Net Debt Issued | · | $18M | · | · | · | $135M | · | · | · | $30M | · | · | $30M | · | · | |
| Stock Issued | · | · | $0 | $0 | · | · | $0 | $0 | · | · | · | · | · | · | · | |
| Stock Repurchased | $200M | $125M | $200M | $203M | $286M | $161M | $75M | $135M | $100M | $75M | $50M | $50M | $100M | $285M | $90M | |
| Net Stock Activity | · | $-125M | · | · | · | $-161M | · | · | · | $-75M | · | · | $-100M | · | · | |
| Financing Cash Flow | $-168M | $120M | $-206M | $-127M | $56M | $89M | $-204M | $-41M | $-114M | $-151M | $394M | $248M | $21M | $-194M | $74M | |
| Net Change in Cash | $19M | $-18M | $20M | $-9M | $18M | $5M | $-4M | $-12M | $-21M | $-12M | $5M | $29M | $9M | $-6M | $15M | |
| Free Cash Flow | · | $-122M | · | · | · | $6M | · | · | · | $156M | · | · | $-4M | · | · | |
| Levered FCF | · | $-151M | · | · | · | $-21M | · | · | · | $134M | · | · | $-15M | · | · |
الربحية
| المقياس | اتجاه | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 31.8% | 31.8% | · | 30.7% | 31.4% | 31.6% | · | 31.3% | 32.5% | 31.9% | · | 31.5% | 31.6% | · | 29.8% | |
| Operating Margin | 5.0% | 5.4% | · | 4.9% | 4.7% | 5.5% | · | 5.0% | 5.1% | 4.7% | · | 6.3% | 5.7% | · | 6.9% | |
| Net Margin | 2.7% | 3.2% | · | 3.0% | 2.6% | 3.5% | · | 3.1% | 3.3% | 2.9% | · | 4.3% | 4.0% | · | 4.9% | |
| Pretax Margin | 4.0% | 4.5% | · | 4.0% | 3.7% | 4.6% | · | 4.0% | 4.2% | 4.0% | · | 5.7% | 5.3% | · | 6.7% | |
| EBITDA Margin | 7.4% | 7.8% | · | 7.3% | 4.7% | 7.8% | · | 5.0% | 5.1% | 7.0% | · | 6.3% | 7.4% | · | 6.9% | |
| ROA | 0.84% | 0.98% | · | 0.93% | 0.81% | 1.1% | · | 0.97% | 1.1% | 0.99% | · | 1.5% | · | · | 1.8% | |
| ROE | 2.9% | 3.2% | · | 2.9% | 2.5% | 3.2% | · | 2.8% | 2.9% | 2.6% | · | 3.8% | · | · | 4.2% | |
| ROIC | 3.1% | 3.1% | · | 3.0% | 2.6% | 3.2% | · | 2.8% | 3.0% | 2.9% | · | 4.3% | · | · | 4.4% |
السيولة والملاءة
| المقياس | اتجاه | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.3 | 1.4 | · | 1.4 | 1.4 | 1.4 | · | 1.4 | 1.5 | 1.7 | · | 2.0 | · | · | 1.8 | |
| Quick Ratio | 0.6 | 0.6 | · | 0.6 | 0.6 | 0.6 | · | 0.6 | 0.7 | 0.8 | · | 0.8 | · | · | 0.7 | |
| Debt / Equity | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.2 | 0.1 | 0.1 | · | 0.0 | · | · | 0.0 | |
| Interest Coverage | 4.0 | 4.7 | · | 4.3 | 4.0 | 5.0 | · | 4.6 | 5.0 | 5.0 | · | 8.0 | 12.5 | · | 19.2 |
الكفاءة
| المقياس | اتجاه | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | · | · | 0.4 | |
| Inventory Turnover | 1.2 | 1.2 | · | 1.3 | 1.2 | 1.2 | · | 1.2 | 1.2 | 1.2 | · | 1.2 | · | · | 1.2 | |
| Receivables Turnover | 2.0 | 2.0 | · | 2.0 | 2.0 | 2.0 | · | 2.0 | 2.1 | 2.0 | · | 2.1 | · | · | 2.0 |
لكل سهم
| المقياس | اتجاه | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $28.21 | $28.54 | · | $28.35 | $28.26 | $27.08 | · | $27.99 | $27.64 | $28.02 | · | $28.10 | · | · | $26.70 | |
| Revenue / Share | $30.23 | $29.02 | · | $27.59 | $26.42 | $25.37 | · | $24.98 | $24.38 | $24.44 | · | $24.06 | $23.00 | · | $22.37 | |
| Cash Flow / Share | · | $-0.84 | · | · | · | $0.30 | · | · | · | $1.52 | · | · | $0.20 | · | · | |
| Cash / Share | $1.40 | $1.21 | · | $1.15 | $1.19 | $1.04 | · | $1.01 | $1.09 | $1.24 | · | $1.28 | · | · | · | |
| EPS (TTM) | $3.43 | $3.31 | · | $3.17 | $3.11 | $3.21 | · | $2.44 | $2.71 | $2.97 | · | $3.38 | $3.52 | · | $4.59 |
التقييم (آخر 12 شهرًا)
| المقياس | اتجاه | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $13.60B | $13.38B | · | $12.94B | $12.77B | $12.67B | · | $12.50B | $12.49B | $12.45B | · | $12.69B | $12.53B | · | $12.61B | |
| Net Income TTM | $403M | $395M | · | $391M | $389M | $407M | · | $314M | $352M | $388M | · | $445M | $478M | · | $638M | |
| Market Cap | $9.51B | $8.25B | · | $7.83B | $8.93B | $8.39B | · | $9.16B | $8.15B | $9.70B | · | $9.65B | · | · | $9.11B | |
| Enterprise Value | $10.37B | $9.16B | · | $8.61B | $9.69B | $9.13B | · | $9.68B | $8.51B | $9.81B | · | $9.49B | · | · | · | |
| P/E | 24.8 | 21.8 | · | 20.8 | 23.6 | 21.4 | · | 30.0 | 23.7 | 25.4 | · | 22.0 | 23.2 | · | 14.7 | |
| P/S | 0.7 | 0.6 | · | 0.6 | 0.7 | 0.7 | · | 0.7 | 0.7 | 0.8 | · | 0.8 | · | · | 0.7 | |
| P/B | 3.0 | 2.5 | · | 2.3 | 2.6 | 2.5 | · | 2.6 | 2.3 | 2.7 | · | 2.6 | · | · | 2.5 | |
| P / Tangible Book | · | · | · | · | · | · | · | · | · | · | · | · | · | · | 85.9 | |
| P / Cash Flow | · | -85.1 | · | · | · | 226.7 | · | · | · | 49.3 | · | · | · | · | · | |
| EV / Revenue | 0.8 | 0.7 | · | 0.7 | 0.8 | 0.7 | · | 0.8 | 0.7 | 0.8 | · | 0.7 | · | · | · | |
| Earnings Yield | 4.0% | 4.6% | · | 4.8% | 4.2% | 4.7% | · | 3.3% | 4.2% | 3.9% | · | 4.5% | 4.3% | · | 6.8% |
أحدث فترة على اليسار · القيم الفارغة معروضة كـ ·
القوائم المالية قائمة الدخل، الميزانية العمومية، التدفقات النقدية — سنويًا، آخر 5 سنوات
| المقياس | 2025-12-27 | 2024-12-28 | 2023-12-30 | 2022-12-31 | 2021-12-25 |
|---|---|---|---|---|---|
| الإيرادات | $13.18B | $12.67B | $12.34B | $12.65B | $12.40B |
| هامش الربح الإجمالي % | 31.1% | 31.7% | 31.3% | 30.3% | 29.6% |
| هامش الربح التشغيلي % | 5.0% | 4.9% | 5.0% | 5.9% | 6.9% |
| صافي الدخل | $398M | $390M | $416M | $538M | $631M |
| EPS المخفف | $3.27 | $3.05 | $3.16 | $3.91 | $4.45 |
| المقياس | 2025-12-27 | 2024-12-28 | 2023-12-30 | 2022-12-31 | 2021-12-25 |
|---|---|---|---|---|---|
| الدين / حقوق الملكية | 0.2 | 0.2 | 0.1 | 0.0 | 0.0 |
| النسبة الحالية | 1.4 | 1.4 | 1.7 | 1.8 | 1.7 |
| النسبة السريعة | 0.6 | 0.6 | 0.8 | 0.7 | 0.7 |
| المقياس | 2025-12-27 | 2024-12-28 | 2023-12-30 | 2022-12-31 | 2021-12-25 |
|---|---|---|---|---|---|
| التدفق النقدي الحر | $573M | $700M | $353M | $506M | $631M |
الملاك المؤسسيون (13F) 600 مقدم إقرار · $11.2B إجمالي · حتى تاريخ 30 سبتمبر، 2026
المؤسسات التي تبلغ عن حيازتها لهذا السهم في نموذج SEC 13F ربع السنوي الخاص بها. المراكز الطويلة فقط؛ قد يظهر مقدم واحد مرتين لأرجل خيارات منفصلة. الأرجل الكبيرة المتعاكسة من خيارات البيع/الشراء تعكس عادةً صناعة السوق أو المخزون المتحوط، وليس القناعة الاتجاهية.
| مراكز جديدة | المراكز الخارجة | زيادة | انخفض | صافي التغير في الأسهم |
|---|---|---|---|---|
| 64 (-16 مقابل الربع السابق) | 60 (+14 مقابل الربع السابق) | 173 (-3 مقابل الربع السابق) | 220 (+25 مقابل الربع السابق) | +9.1M |
مقارنة بـ Q1 2026. المواعيد النهائية لتقديم إقرارات نموذج 13F لهيئة الأوراق المالية والبورصات (SEC) هي في غضون 45 يومًا من نهاية الربع بالإضافة إلى فترة سماح قصيرة للمقدمين المتأخرين — يتم تخطي الأرباع التي لا تزال ضمن هذه النافذة لصالح أحدث زوج تم الإبلاغ عنه بالكامل.
| مؤسسة | القيمة | الأسهم | % من 13F المتتبعة | النوع |
|---|---|---|---|---|
| Kohlberg Kravis Roberts & Co. L.P. | $1307257713 | 15652032 | 11,68% | الأسهم |
| VANGUARD GROUP INC | $875836080 | 11588199 | 7,82% | الأسهم |
| FMR LLC | $630901802 | 7553901 | 5,64% | الأسهم |
| BlackRock, Inc. | $586699894 | 7024663 | 5,24% | الأسهم |
| Artisan Partners Limited Partnership | $540162844 | 6467467 | 4,82% | الأسهم |
| VANGUARD CAPITAL MANAGEMENT LLC | $530073795 | 6346669 | 4,73% | الأسهم |
| JPMORGAN CHASE & CO | $366432667 | 4342929 | 3,27% | الأسهم |
| STATE STREET CORP | $359576652 | 4305276 | 3,21% | الأسهم |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $345225076 | 4133442 | 3,08% | الأسهم |
| AMERICAN CENTURY COMPANIES INC | $288743396 | 3457175 | 2,58% | الأسهم |
| DIMENSIONAL FUND ADVISORS LP | $283495786 | 3394242 | 2,53% | الأسهم |
| Southpoint Capital Advisors LP | $275616000 | 3300000 | 2,46% | الأسهم |
| Invesco Ltd. | $263107794 | 3150237 | 2,35% | الأسهم |
| CITADEL ADVISORS LLC | $243970523 | 2921103 | 2,18% | الأسهم |
| GEODE CAPITAL MANAGEMENT, LLC | $227537373 | 2729030 | 2,03% | الأسهم |
| Palestra Capital Management LLC | $204347632 | 2446691 | 1,83% | الأسهم |
| BANK OF MONTREAL /CAN/ | $176687394 | 2115510 | 1,58% | الأسهم |
| MORGAN STANLEY | $175460572 | 2100819 | 1,57% | الأسهم |
| FIDUCIARY MANAGEMENT INC /WI/ | $151785323 | 1817353 | 1,36% | الأسهم |
| Burgundy Asset Management Ltd. | $151049204 | 2170871 | 1,35% | الأسهم |
| LYRICAL ASSET MANAGEMENT LP | $122553156 | 1467351 | 1,09% | الأسهم |
| UBS Group AG | $111653127 | 1336843 | 1,00% | الأسهم |
| Swedbank AB | $109479854 | 1310822 | 0,98% | الأسهم |
| M.D. Sass, LLC | $107485396 | 1286942 | 0,96% | الأسهم |
| SNYDER CAPITAL MANAGEMENT L P | $107341992 | 1285225 | 0,96% | الأسهم |
| SCHRODER INVESTMENT MANAGEMENT GROUP | $107262144 | 1272537 | 0,96% | الأسهم |
| NORGES BANK | $103383729 | 1237832 | 0,92% | الأسهم |
| BANK OF AMERICA CORP /DE/ | $101266079 | 1212477 | 0,90% | الأسهم |
| GOLDMAN SACHS GROUP INC | $98070544 | 1174216 | 0,88% | الأسهم |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $86593118 | 1036795 | 0,77% | الأسهم |
| NORTHERN TRUST CORP | $80548694 | 964424 | 0,72% | الأسهم |
| NOMURA HOLDINGS INC | $77065658 | 922721 | 0,69% | الأسهم |
| PZENA INVESTMENT MANAGEMENT LLC | $71888420 | 860733 | 0,64% | الأسهم |
| DME Capital Management, LP | $60013296 | 718550 | 0,54% | الأسهم |
| Ananym Capital Management, LP | $57978164 | 694183 | 0,52% | الأسهم |
| Ulysses Management LLC | $55570700 | 665358 | 0,50% | الأسهم |
| STALEY CAPITAL ADVISERS INC | $55252489 | 661548 | 0,49% | الأسهم |
| VANGUARD FIDUCIARY TRUST CO | $45489502 | 544654 | 0,41% | الأسهم |
| RAYMOND JAMES FINANCIAL INC | $42948907 | 514235 | 0,38% | الأسهم |
| Bank of New York Mellon Corp | $42261071 | 505999 | 0,38% | الأسهم |
| Nuveen, LLC | $38262099 | 458119 | 0,34% | الأسهم |
| DEUTSCHE BANK AG\ | $36574075 | 437908 | 0,33% | الأسهم |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $35970895 | 430686 | 0,32% | الأسهم |
| Clarkston Capital Partners, LLC | $35168100 | 421074 | 0,31% | الأسهم |
| LONE PEAK GLOBAL INVESTORS LLC | $33404158 | 399954 | 0,30% | الأسهم |
| GAMCO INVESTORS, INC. ET AL | $30537668 | 365633 | 0,27% | الأسهم |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $27342332 | 370995 | 0,24% | الأسهم |
| PRIVATE MANAGEMENT GROUP INC | $27285483 | 326694 | 0,24% | الأسهم |
| FRANKLIN RESOURCES INC | $25575244 | 306217 | 0,23% | الأسهم |
| BNP PARIBAS FINANCIAL MARKETS | $25194142 | 301654 | 0,23% | الأسهم |
الناشطون والمالكون بنسبة 5%+ 2 حيازتان
المستثمرون الذين قدموا الجدول الزمني 13D لدى هيئة الأوراق المالية والبورصات — ملكية مستفيدة تزيد عن 5% مع نية التأثير على المُصدر (حصص الناشطين، حملات مجلس الإدارة، الاندماج والاستحواذ). يعرض كل صف أحدث حالة معروفة لمركز مقدم الطلب هذا.
| مقدم | مقدم | حصة | الحالة | الغرض | إيداع |
|---|---|---|---|---|---|
| KKR Hawaii Holdings L.P., KKR Hawaii Holdings GP LLC, KKR Hawaii Aggregator L.P., KKR Hawaii Aggregator GP LLC, KKR North America Fund XIII SCSp, KKR Associates North America XIII SCSp, KKR North America XIII S.a r.l., KKR North America XIII Holdings Limited, MH Sub I, LLC, Indigo Intermediate Co II, LLC, IB Aggregator II L.P., KKR Indigo Aggregator III GP LLC, KKR Americas Fund XII (Indigo) L.P., KKR Associates Americas XII AIV L.P., KKR Americas XII AIV GP LLC, KKR Group Partnership L.P., KKR Group Holdings Corp., KKR Group Co. Inc., KKR & Co. Inc., KKR Management LLP, Henry R. Kravis, George R. Roberts ×4 إيداعات | 10 مارس، 2026 | 16,40% | تعديل | · | SEC |
| KKR Hawaii Aggregator L.P., KKR Hawaii Aggregator GP LLC, KKR North America Fund XIII SCSp, KKR Associates North America XIII SCSp, KKR North America XIII S.a r.l., KKR North America XIII Holdings Limited, MH Sub I, LLC, Indigo Intermediate Co II, LLC, IB Aggregator II L.P., KKR Indigo Aggregator III GP LLC, KKR Americas Fund XII (Indigo) L.P., KKR Associates Americas XII AIV L.P., KKR Americas XII AIV GP LLC, KKR Group Partnership L.P., KKR Group Holdings Corp., KKR Group Co. Inc., KKR & Co. Inc., KKR Management LLP, Henry R. Kravis, George R. Roberts ×4 إيداعات | 8 أغسطس، 2025 | 13,00% | تعديل | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
المطلعون على الشركة 52 من المطلعين · مسؤولون 25 · مديرون 22
| مطلع | الدور | آخر نشاط | الأسهم المملوكة | مشتريات 12 شهرًا | مبيعات 12 شهرًا | صافي 12 شهرًا |
|---|---|---|---|---|---|---|
| Andrea Albertini | CEO, Global Dist. & Tech. | 8 سبتمبر، 2026 D | 116104 | 0 | 0 | $0 |
| Thomas C Popeck | CEO, Henry Schein Products | 19 مارس، 2026 S | 86182 | 0 | 1 | $-98630 |
| Frederick M. Lowery | CEO | 6 مارس، 2026 A | 95156 | 0 | 0 | $0 |
| Bradford C Connett | CEO, NA Distribution Group | 19 مارس، 2025 S | 62688 | 0 | 0 | $0 |
| David B Brous Jr | CEO, Strategic Business Group | 12 يونيو، 2023 S | 68690 | 0 | 0 | $0 |
| Karen Prange | EVP&CEO Gl.AH.Med.Den.Sur.Grp | 2 مارس، 2018 A | 62902 | 0 | 0 | $0 |
| Lonnie Shoff | CEO, Global Strat Port Grp | 15 مارس، 2016 S | 31000 | 0 | 0 | $0 |
| Ronald N. South | SVP & Chief Financial Officer | 16 مارس، 2026 F | 88930 | 0 | 0 | $0 |
| James P Breslawski | President | 14 مارس، 2025 D | 200227 | 0 | 0 | $0 |
| Bridget A Ross | President, Global Medical Grp | 6 مارس، 2017 A | 9654 | 0 | 0 | $0 |
| Michael Zack | President of Int'l Group | 7 مارس، 2013 M | 48716 | 0 | 0 | $0 |
| Michael S Ettinger | EVP & Chief Operating Officer | 17 مارس، 2026 G | 112208 | 0 | 0 | $0 |
| Christine Zayac Sheehy | SVP, Chief Human Res. Officer | 16 مارس، 2026 F | 18454 | 0 | 0 | $0 |
| Mark E Mlotek | EVP, Chief Strategic Officer | 16 مارس، 2026 F | 98372 | 0 | 2 | $-478758 |
| Walter Siegel | Sr. VP & Chief Legal Officer | 14 مارس، 2025 D | 43191 | 0 | 0 | $0 |
| Lorelei Mcglynn | SVP, Chief Human Res. Officer | 6 سبتمبر، 2024 S | 71833 | 0 | 0 | $0 |
| Gerald A Benjamin | EVP, Chief Admin. Officer | 26 مايو، 2022 S | 95616 | 0 | 0 | $0 |
| David Mckinley | CCO&Pres. Corp. Com. Dev. Grp. | 30 نوفمبر، 2018 S | 68012 | 0 | 0 | $0 |
| Paul Rose | SVP, Global Supply Chain | 6 سبتمبر، 2017 S | 17841 | 0 | 0 | $0 |
| Robert Minowitz | Pres., Int'l Dental Group EMEA | 12 مايو، 2017 S | 22943 | 0 | 0 | $0 |
| Michael Racioppi | SVP Chief Merchandising Offic. | 20 مارس، 2017 M | 23088 | 0 | 0 | $0 |
| Peter M. Mccarthy | Pres., Global Animal Health | 13 مارس، 2017 S | 14277 | 0 | 0 | $0 |
| James A. Harding | SVP, Chief Technology Officer | 8 مارس، 2017 S | 16589 | 0 | 0 | $0 |
| Stanley Komaroff | Senior Advisor | 2 مارس، 2016 F | 25144 | 0 | 0 | $0 |
| Leonard A David | SVP, Chief Compliance Officer | 17 مارس، 2015 S | 12343 | 0 | 0 | $0 |
| William K Daniel | مدير | 12 يونيو، 2026 A | 7641 | 1 | 0 | $691900 |
| Scott Philip Serota | مدير | 6 مارس، 2026 A | 10790 | 0 | 0 | $0 |
| Carole T Faig | مدير | 6 مارس، 2026 A | 8025 | 0 | 0 | $0 |
| Anne H. Margulies | مدير | 6 مارس، 2026 A | 23153 | 0 | 0 | $0 |
| Mohamad Ali | مدير | 6 مارس، 2026 A | 15075 | 0 | 0 | $0 |
| Reed Vaughn Tuckson | مدير | 6 مارس، 2026 A | 12520 | 0 | 0 | $0 |
| Robert J. Hombach | مدير | 6 مارس، 2026 A | 5421 | 0 | 0 | $0 |
| Bradley T Sheares | مدير | 6 مارس، 2026 A | 47623 | 0 | 0 | $0 |
| Philip A Laskawy | مدير | 6 مارس، 2026 A | 24538 | 0 | 1 | $-228544 |
| Carol Raphael | مدير | 21 مايو، 2025 F | 33538 | 0 | 0 | $0 |
| Steven Paladino | مدير | 4 مارس، 2024 A | 138272 | 0 | 0 | $0 |
| Dianne E Rekow | مدير | 16 مارس، 2022 A | 18526 | 0 | 0 | $0 |
| Barry J Alperin | مدير | 16 مارس، 2022 A | 52473 | 0 | 0 | $0 |
| Paul Brons | مدير | 3 مارس، 2021 F | 16854 | 0 | 0 | $0 |
| Shira Goodman | مدير | 3 مارس، 2021 A | 5689 | 0 | 0 | $0 |
| Lawrence S Bacow | مدير | 6 مارس، 2018 F | 10115 | 0 | 0 | $0 |
| Donald J Kabat | مدير | 6 مارس، 2018 F | 10874 | 0 | 0 | $0 |
| Louis W Sullivan | مدير | 31 مارس، 2016 A | 14096 | 0 | 0 | $0 |
| Norman S Matthews | مدير | 31 مارس، 2016 A | 12890 | 0 | 0 | $0 |
| Karyn Mashima | مدير | 10 مارس، 2014 F | 19269 | 0 | 0 | $0 |
| Irving Shafran | مدير | 20 نوفمبر، 2003 S | 750000 | 0 | 0 | $0 |
| Stanley M Bergman | · | 26 مايو، 2026 G | 253279 | 0 | 5 | $-7544687 |
| Kurt P Kuehn | · | 10 مارس، 2026 S | 15420 | 0 | 1 | $-224562 |
| Deborah Derby | · | 6 مارس، 2026 A | 15093 | 0 | 0 | $0 |
| Joseph L Herring | · | 6 مارس، 2026 A | 30325 | 0 | 0 | $0 |
| Margaret A Hamburg | · | 20 مايو، 2009 M | 0 | 0 | 0 | $0 |
| Pamela Joseph | · | 16 نوفمبر، 2004 S | 98879 | 0 | 0 | $0 |
المطلعون من إيداعات SEC Form 3/4/5؛ صافي = سوق مفتوح فقط
ملكية صناديق المؤشرات المتداولة محتفظ بها بواسطة 86 صناديق مؤشرات متداولة
الوزن يعكس فقط ممتلكات الأسهم المباشرة (N-PORT)؛ قد تحتفظ الصناديق المضاعفة أو القائمة على المشتقات بتعرض إضافي للمقايضة غير معروض.
| صندوق | الوزن | الوحدات | حتى تاريخ | المصدر |
|---|---|---|---|---|
| RSPH · Invesco Exchange-Traded Fund Trust | 1,59% | 163520 SH | 2 أكتوبر، 2026 | يومي |
| GURU · Global X Funds | 1,29% | 9179 NS | 31 يوليو، 2026 | N-PORT |
| FXH · First Trust Exchange-Traded AlphaDE… | 0,87% | 106077 NS | 31 يوليو، 2026 | N-PORT |
| RPV · Invesco Exchange-Traded Fund Trust | 0,65% | 126921 SH | 2 أكتوبر، 2026 | يومي |
| FBCV · FIDELITY COVINGTON TRUST | 0,36% | 7509 NS | 31 يوليو، 2026 | N-PORT |
| JPME · J.P. Morgan Exchange-Traded Fund Tr… | 0,33% | 18150 NS | 31 يوليو، 2026 | N-PORT |
| IQSM · New York Life Investments ETF Trust | 0,33% | 12855 NS | 31 يوليو، 2026 | N-PORT |
| PKW · Invesco Exchange-Traded Fund Trust | 0,28% | 54697 SH | 2 أكتوبر، 2026 | يومي |
| BKMC · BNY Mellon ETF Trust | 0,23% | 17140 NS | 31 يوليو، 2026 | N-PORT |
| DFAT · Dimensional ETF Trust | 0,22% | 364767 NS | 31 يوليو، 2026 | N-PORT |
| RSP · Invesco Exchange-Traded Fund Trust | 0,20% | 2218557 SH | 2 أكتوبر، 2026 | يومي |
| FSMD · FIDELITY COVINGTON TRUST | 0,20% | 57583 NS | 31 يوليو، 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,19% | 343006 NS | 31 يوليو، 2026 | N-PORT |
| ESML · iShares Trust | 0,18% | 58607 SH | 11 سبتمبر، 2026 | يومي |
| BBMC · J.P. Morgan Exchange-Traded Fund Tr… | 0,17% | 41019 NS | 31 يوليو، 2026 | N-PORT |
| VBR · VANGUARD INDEX FUNDS | 0,17% | 1416056 SH | 19 أغسطس، 2026 | يومي |
| FNX · First Trust Exchange-Traded AlphaDE… | 0,15% | 24666 NS | 31 يوليو، 2026 | N-PORT |
| FNK · First Trust Exchange-Traded AlphaDE… | 0,15% | 3879 NS | 31 يوليو، 2026 | N-PORT |
| IYH · iShares Trust | 0,14% | 57526 SH | 11 سبتمبر، 2026 | يومي |
| NUSC · Nushares ETF Trust | 0,14% | 20654 NS | 31 يوليو، 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0,12% | 46652 NS | 31 يوليو، 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0,12% | 293098 SH | 19 أغسطس، 2026 | يومي |
| SMMD · iShares Trust | 0,12% | 52697 SH | 11 سبتمبر، 2026 | يومي |
| IXJ · iShares Trust | 0,11% | 51636 SH | 11 سبتمبر، 2026 | يومي |
| VB · VANGUARD INDEX FUNDS | 0,10% | 2230411 SH | 19 أغسطس، 2026 | يومي |
| CURE · Direxion Shares ETF Trust | 0,10% | 1905 NS | 31 يوليو، 2026 | N-PORT |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0,09% | 8660 SH | 2 أكتوبر، 2026 | يومي |
| VFMF · VANGUARD WELLINGTON FUND | 0,09% | 7550 SH | 19 أغسطس، 2026 | يومي |
| IWS · iShares Trust | 0,08% | 146411 SH | 10 سبتمبر، 2026 | يومي |
| TILT · FlexShares Trust | 0,08% | 20224 NS | 31 يوليو، 2026 | N-PORT |
| WSML · iShares Trust | 0,08% | 6020 SH | 11 سبتمبر، 2026 | يومي |
| VFVA · VANGUARD WELLINGTON FUND | 0,07% | 7214 SH | 19 أغسطس، 2026 | يومي |
| RWL · Invesco Exchange-Traded Fund Trust … | 0,07% | 77119 SH | 2 أكتوبر، 2026 | يومي |
| JVAL · J.P. Morgan Exchange-Traded Fund Tr… | 0,07% | 6494 NS | 31 يوليو، 2026 | N-PORT |
| IWR · iShares Trust | 0,06% | 403437 SH | 11 سبتمبر، 2026 | يومي |
| DFUV · Dimensional ETF Trust | 0,06% | 98929 NS | 31 يوليو، 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0,05% | 13423 NS | 31 يوليو، 2026 | N-PORT |
| XOEF · iShares Trust | 0,05% | 125 SH | 11 سبتمبر، 2026 | يومي |
| DFAC · Dimensional ETF Trust | 0,05% | 270764 NS | 31 يوليو، 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0,05% | 2999 NS | 31 يوليو، 2026 | N-PORT |
| IUS · Invesco Exchange-Traded Self-Indexe… | 0,04% | 5048 SH | 2 أكتوبر، 2026 | يومي |
| FAB · First Trust Exchange-Traded AlphaDE… | 0,04% | 858 NS | 31 يوليو، 2026 | N-PORT |
| CATH · Global X Funds | 0,04% | 6000 NS | 31 يوليو، 2026 | N-PORT |
| PRF · Invesco Exchange-Traded Fund Trust | 0,04% | 44360 SH | 2 أكتوبر، 2026 | يومي |
| DCOR · Dimensional ETF Trust | 0,03% | 13104 NS | 31 يوليو، 2026 | N-PORT |
| VOOV · VANGUARD ADMIRAL FUNDS | 0,03% | 22387 SH | 19 أغسطس، 2026 | يومي |
| IVE · iShares Trust | 0,03% | 160669 SH | 11 سبتمبر، 2026 | يومي |
| IUSV · iShares Trust | 0,03% | 83684 SH | 11 سبتمبر، 2026 | يومي |
| CHRI · Global X Funds | 0,03% | 24 NS | 31 يوليو، 2026 | N-PORT |
| DSI · iShares Trust | 0,02% | 14799 SH | 10 سبتمبر، 2026 | يومي |
| IWD · iShares Trust | 0,02% | 218760 SH | 11 سبتمبر، 2026 | يومي |
| VONV · VANGUARD SCOTTSDALE FUNDS | 0,02% | 59466 SH | 19 أغسطس، 2026 | يومي |
| EGLE · Global X Funds | 0,02% | 5 NS | 31 يوليو، 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,02% | 25929 NS | 31 يوليو، 2026 | N-PORT |
| XYLG · Global X Funds | 0,02% | 132 NS | 31 يوليو، 2026 | N-PORT |
| QVML · Invesco Exchange-Traded Fund Trust … | 0,02% | 3116 SH | 2 أكتوبر، 2026 | يومي |
| TOPC · iShares Trust | 0,02% | 59 SH | 10 سبتمبر، 2026 | يومي |
| XCLR · Global X Funds | 0,01% | 6 NS | 31 يوليو، 2026 | N-PORT |
| XVV · iShares Trust | 0,01% | 1104 SH | 11 سبتمبر، 2026 | يومي |
| PTLC · Pacer Funds Trust | 0,01% | 5070 NS | 31 يوليو، 2026 | N-PORT |
| IVV · iShares Trust | 0,01% | 1220662 SH | 11 سبتمبر، 2026 | يومي |
| XYLD · Global X Funds | 0,01% | 4788 NS | 31 يوليو، 2026 | N-PORT |
| PBP · Invesco Exchange-Traded Fund Trust | 0,01% | 576 SH | 2 أكتوبر، 2026 | يومي |
| DFUS · Dimensional ETF Trust | 0,01% | 30222 NS | 31 يوليو، 2026 | N-PORT |
| IWB · iShares Trust | 0,01% | 68043 SH | 11 سبتمبر، 2026 | يومي |
| XRMI · Global X Funds | 0,01% | 70 NS | 31 يوليو، 2026 | N-PORT |
| SPUU · Direxion Shares ETF Trust | 0,01% | 365 NS | 31 يوليو، 2026 | N-PORT |
| IWV · iShares Trust | 0,01% | 27083 SH | 9 سبتمبر، 2026 | يومي |
| IYY · iShares Trust | 0,01% | 4036 SH | 10 سبتمبر، 2026 | يومي |
| QDPL · Pacer Funds Trust | 0,01% | 2304 NS | 31 يوليو، 2026 | N-PORT |
| ITOT · iShares Trust | 0,01% | 123729 SH | 11 سبتمبر، 2026 | يومي |
| PHDG · Invesco Actively Managed Exchange-T… | 0,01% | 77 SH | 2 أكتوبر، 2026 | يومي |
| HCMT · Direxion Shares ETF Trust | 0,01% | 674 NS | 31 يوليو، 2026 | N-PORT |
| VOO · VANGUARD INDEX FUNDS | 0,01% | 2513394 SH | 19 أغسطس، 2026 | يومي |
| VTI · VANGUARD INDEX FUNDS | 0,01% | 3089160 SH | 19 أغسطس، 2026 | يومي |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,01% | 81658 SH | 19 أغسطس، 2026 | يومي |
| VONE · VANGUARD SCOTTSDALE FUNDS | 0,01% | 16261 SH | 19 أغسطس، 2026 | يومي |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,01% | 8309 SH | 19 أغسطس، 2026 | يومي |
| ESGV · VANGUARD WORLD FUND | 0,01% | 22281 SH | 19 أغسطس، 2026 | يومي |
| SPXL · Direxion Shares ETF Trust | 0,01% | 7569 NS | 31 يوليو، 2026 | N-PORT |
| XTR · Global X Funds | 0,01% | 4 NS | 31 يوليو، 2026 | N-PORT |
| DFSV · Dimensional ETF Trust | 0,00% | 99 NS | 31 يوليو، 2026 | N-PORT |
| ISCB · iShares Trust | · | 4208 SH | 11 سبتمبر، 2026 | يومي |
| ISCV · iShares Trust | · | 20757 SH | 11 سبتمبر، 2026 | يومي |
| SMLF · iShares Trust | · | 8316 SH | 11 سبتمبر، 2026 | يومي |
| SMMV · iShares Trust | · | 19508 SH | 19 أغسطس، 2026 | يومي |
HSIC توافق الآراء التحليلي آراء المحللين الصعودية والهبوطية، السعر المستهدف لمدة 12 شهرًا، الصعود
السعر المستهدف لمدة 12 شهرًا
15 محللين · 2026-09-30السعر المستهدف المتوسط $97.27 +14,6%
مقارنة الأقران (الصناعة الفرعية GICS) المقاييس الرئيسية مقابل أقران القطاع
أساس السنة المالية، الأسعار كما في إغلاق نهاية السنة المالية الأخيرة لكل شركة.
| الرمز | القيمة السوقية | P/E | الإيرادات سنويًا | هامش الربح الصافي | ROE | هامش الربح الإجمالي |
|---|---|---|---|---|---|---|
| HSIC | $8.81B | 23.3 | 4.0% | 3.0% | 12.0% | 31.1% |
| MCK | $242.30B | 22.5 | 12.4% | 1.2% | -224.3% | 3.6% |
| COR | $60.61B | 39.3 | 9.3% | 0.48% | 144.3% | 3.6% |
| CAH | · | 32.9 | 14.2% | 0.67% | -60.5% | 3.8% |
| AHCO | $1.35B | -19.2 | -0.49% | -2.2% | -4.6% | · |
| ACH | · | · | · | · | · | · |
| MEDS | · | · | · | · | · | · |
آخر الأخبار أحدث العناوين التي تذكر هذه الشركة
إشارات التداول إشارات شراء/بيع حديثة مع سعر الدخول ونسبة المخاطرة/المكافأة
لا توجد إشارة مفتوحة حاليًا — لا توجد بطاقة معبأة، وهذا أمر صادق.
مقاييسي قائمة المراقبة الشخصية الخاصة بك — صفوف مختارة من الأساسيات الكاملة
اختر المقاييس التي تهمك — انقر فوق علامة + بجوار أي صف في الأساسيات الكاملة أعلاه.
يتم حفظ اختيارك ويتبعك عبر جميع الأسهم.